• Bandeau Investisseurs

Key half-yearly figures from 2008 to 2017

Balance sheet assets...

In EUR millions 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08
Goodwill 21.67 21.67 21.79 21.79 21.79 22.29 22.29 22.29 22.74 22.74
Non-current assets 112.29 106.99 100.99 93.17 90.47 84.37 80.17 74.69 72.22 71.50
Current assets 267.07 259.44 232.58 194.45 179.51 170.73 179.12 168.06 150.61 174.37
Inventory 99.66 94.96 89.99 81.35 75.20 73.70 72.86 67.52 67.67 69.91
Receivables 119.30 123.04 111.26 89.89 81.11 74.84 79.24 73.06 58.30 80.10
Other receivables and cash 48.11 41.44 31.33 23.21 23.20 22.18 27.02 27.48 24.65 24.36

 Balance sheet liabilities...

In EUR millions 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08
Shareholders' equity 122.94 116.70 99.36 84.63 74.71 68.81 62.67 58.82 61.32 65.02
Financial liabilities 125.16 118.57 110.06 93.57 97.36 95.72 88.87 91.69 81.20 82.76
Total liabilities and shareolders' equity 379.37 366.43 333.57 287.62 269.97 255.10 259.28 242.74 222.83 245.87

 Income statement...

In EUR millions 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08
Sales 218.17 221.77 183.04 163.82 145.66 145.74 143.44 117.97 105.44 132.29
Payroll charges 55.65 53.35 49.33 46.15 43.84 42.18 41.17 41.45 37.40 37.52
Operating profit 6.31 13.27 7.52 8.01 5.69 3.36 7.22 -0.97 -3.07 7.69
Net income 2.41 10.90 4.68 5.78 3.79 0.25 3.62 -4.29 -3.71 2.97

 Other indicators...

In EUR millions 30/06/17 30/06/16 30/06/15 30/06/ 14 30/06/ 13 30/06/ 12 30/06/ 11 30/06/ 10 30/06/ 09 30/06/ 08
Staff 3 315 3 141 2 921 2 763 2 673 2 773 2 786 2 557 2 367 2 401
Research & Development 31.66 29.78 25.12 22.47 21.53 22.91 20.26 19.95 19.32 20.26
EBITDA 11.07 21.03 12.92 14.44 11.43 6.95 11.30 3.66 1.28 10.24

 Ratios...

Percentage 30/06/17 30/06/16 30/06/15 30/06/ 14 30/06/ 13 30/06/ 12 30/06/ 11 30/06/ 10 30/06/ 09 30/06/ 08
Payroll charges / sales 26% 24% 27% 28% 30% 29% 29% 35% 35% 28%
Net income / sales 1% 5% 3% 4% 3% 0% 3% -4% -3% 3%
Net income / shareholders' equity 2% 9% 5% 7% 5% 0% 6% -7% -6% 5%
Research & Development / sales 15% 13% 14% 14% 15% 16% 14% 17% 18% 15%
Bookmark and Share